Cannula Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Cannula Market is projected to expand from USD 226.59 Million in 2025 to USD 357.78 Million by 2031, exhibiting a CAGR of 7.91%. Defined as flexible tubes typically containing retractable inner cores, cannulas are essential for fluid drainage or medication administration within bodily cavities or vessels. The industry is primarily propelled by the increasing prevalence of chronic diseases requiring prolonged intravenous therapy and an aging population, which leads to higher hospitalization rates. Additionally, the widespread adoption of minimally invasive medical techniques mandates the consistent use of these devices for accurate vascular access and fluid management, ensuring a stable demand trajectory beyond temporary market shifts.

Despite these growth factors, the danger of catheter-related bloodstream infections constitutes a major obstacle, leading to tighter regulatory controls and increased healthcare expenses. This urgent necessity for safer vascular access solutions is reinforced by significant disease burden metrics; according to the American Heart Association's most recent comprehensive data from 2025, cardiovascular disease was responsible for roughly 19.41 million deaths worldwide, highlighting the massive volume of patients needing medical care.

Market Drivers

The increasing popularity of aesthetic and cosmetic procedures has become a crucial catalyst for the global cannula market, particularly driving the use of blunt-tip microcannulas. These specialized instruments are being chosen over conventional hypodermic needles for soft tissue filler applications because they reduce patient bruising, alleviate pain, and significantly decrease the risk of vascular occlusion. This transition is supported by the rapid growth of the non-invasive sector; as per the International Society of Aesthetic Plastic Surgery's 'Global Survey 2024 Press Release' from June 2025, non-surgical interventions rose to approximately 20.5 million procedures globally. Consequently, manufacturers are compelled to develop flexible, safety-focused designs for facial contouring, establishing a lucrative niche within the vascular access market.

Concurrently, the escalating global incidence of chronic lifestyle and respiratory conditions demands sustained therapeutic interventions, securing the market's foundational volume. Diseases like diabetes and chronic obstructive pulmonary disease (COPD) necessitate frequent drug administration or continuous oxygen therapy, maintaining the requirement for superior intravenous and nasal cannulas. For example, the International Diabetes Federation's 'IDF Diabetes Atlas 11th Edition' in 2025 estimated that 589 million adults worldwide were living with diabetes, representing a demographic heavily dependent on insulin delivery mechanisms. This extensive disease burden guarantees reliable revenue for medical device firms; ICU Medical reported in their 'Third Quarter 2025 Financial Results' in November 2025 that quarterly revenues hit roughly $537 million, illustrating the persistent demand for vital infusion and critical care supplies.

Market Challenges

The ongoing threat of catheter-related bloodstream infections and complications associated with vascular access remains a significant hurdle to the Global Cannula Market's progress. This safety issue severely limits market growth by necessitating strict regulatory supervision and increasing liability risks for healthcare providers. As regulators implement more rigorous safety protocols to address these dangers, manufacturers must dedicate substantial resources to compliance and quality assurance, which drives up production costs and prolongs approval periods for new devices. These financial and procedural challenges establish high entry barriers and retard the launch of innovative products, effectively constraining the overall speed of market evolution.

The gravity of this challenge is emphasized by the high incidence of device-related failures in clinical environments. According to data from the Association for Vascular Access in 2024, the failure rate of peripheral intravenous catheters in hospitalized patients fell between 35% and 50%. Such a high rate of failure compels medical institutions to direct considerable funds toward managing complications and conducting re-insertion procedures. As a result, hospitals frequently employ conservative purchasing strategies that favor thorough validation over high volume, which directly inhibits the rapid uptake and global volume expansion of cannula products.

Market Trends

Healthcare institutions are increasingly standardizing the adoption of safety IV cannulas featuring automatic needle-shielding technology to reduce occupational risks. This movement is a direct reaction to more stringent safety regulations designed to eliminate needle-stick injuries among medical staff and prevent cross-contamination during vascular access processes. In response, manufacturers are significantly scaling up production capacities to satisfy this regulation-led demand for protective equipment. According to a January 2025 press release titled 'BD Boosts U.S. Manufacturing of Critical Medical Devices,' Becton, Dickinson and Company announced investments to increase their manufacturing capacity for safety-engineered injection devices by over 40 percent to support essential healthcare delivery requirements.

At the same time, there is a clear transition toward developing user-friendly cannulas tailored for home-based care, especially regarding respiratory therapy and long-term infusion. As medical care shifts from hospital settings to patients' homes, there is a rising demand for durable, low-maintenance devices that enable individuals to independently manage chronic issues such as sleep apnea and respiratory distress. This shift toward home care is driving significant revenue increases for specialized device makers. As noted in Fisher & Paykel Healthcare's 'Annual Report 2025' from May 2025, revenue for their Homecare product group, which includes devices for community-based respiratory support, hit approximately $740 million, marking a 13% rise over the prior financial year.

Key Players Profiled in the Cannula Market

• Medtronic PLC
• Becton Dickinson (BD) & Company
• Edward Lifesciences Corporation
• LivaNovaca PLC
• Smiths Medical MD Inc.
• Boston Scientific Corporation
• Hindustan Syringes and Medical Devices Ltd (HMD)
• Sterimedix Ltd.
• Angiplast Pvt. Ltd.
• Sterimed Group

Report Scope

In this report, the Global Cannula Market has been segmented into the following categories:

Cannula Market, by Product:

• Cardiac
• Dermatology
• Nasal
• Others

Cannula Market, by Type:

• Neonatal Cannulae
• Straight Cannulae
• Winged Cannulae
• Wing With Port
• Winged With Stop Cork

Cannula Market, by Material:

• Plastic
• Metal
• Silicone

Cannula Market, by Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

Cannula Market, by End-Use Industry:

• Hospital
• Ambulatory Surgical Centers
• Others

Cannula Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cannula Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.